Skip to main content
search

Postoperative Nausea and Vomiting – Prevention and Treatment

The Anesthesia Guide » Topics » Postoperative Nausea and Vomiting – Prevention and Treatment

Author:
Kai Knudsen

Granskare:

Magnus Snäckestrand



Updated:
27 August, 2025

This chapter describes how to prevent nausea and the various medications that can be administered to counteract nausea associated with anesthesia and surgery.

Postoperative Nausea – PONV


Postoperative nausea and vomiting (PONV) has long been a significant problem in anesthesia and intensive care. In fact, this issue is what most concerns many patients before their upcoming anesthesia. During the preoperative conversation, it is often the fear of postoperative nausea that the patient first brings up. It has been shown that the choice of anesthesia technique is important for the occurrence of PONV, as well as the presence of various risk factors and the type of surgery involved. PONV can be somewhat prevented by administering one or more antiemetics perioperatively. Inhalation anesthesia results in significantly more PONV compared to intravenous anesthesia; however, there is no significant difference between desflurane and sevoflurane. The incidence of PONV is around 10-20%, in some groups up to 40%. The use of nitrous oxide increases the risk of nausea. Blood pressure drops, bradycardia, and hypoxia can trigger nausea and vomiting, as can prolonged fasting or constipation. The type of surgery naturally also plays a role. High risk of PONV is associated with abdominal surgery and breast surgery. Diabetes causes delayed gastrointestinal motility. A high dose of neostigmine for reversal of muscle relaxants increases the risk of PONV.

Postoperative nausea is common and bothersome

As preventive treatment, dopamine receptor blockers (droperidol, metoclopramide) or 5-HT3 blockers (ondansetron, granisetron) are usually used. The commonly used medications are Zofran (ondansetron), Kytril (granisetron), Betapred (betamethasone), Primperan (metoclopramide), or Dridol (droperidol). Granisetron is significantly longer-acting compared to ondansetron. A combination of 5-HT3 blockers plus betamethasone or Dridol has better efficacy than a single drug alone. The combination of 5-HT3 blockers with Dridol provides approximately the same positive effect as a combination with betamethasone. A probably better alternative to betamethasone is dexamethasone, where the scientific evidence for prophylactic effect against nausea is greater.

Suggestions for Prophylaxis Against PONV

  • Low risk of PONV: ondansetron alone.
  • Moderate risk of PONV: ondansetron plus betamethasone/dexamethasone.
  • High risk of PONV: ondansetron, droperidol plus betamethasone/dexamethasone.

Transient ECG changes, including QT interval prolongation, have been reported in rare cases with 5-HT3 blockers. Caution should be exercised in patients with prolonged QT syndrome or arrhythmias.

Risk Factors for PONV

  • Young patient
  • Female gender
  • Anxious patient
  • Prone to motion sickness
  • Non-smoker
  • Previous nausea during anesthesia
  • Constipation or other gastrointestinal issues
  • Prolonged fasting
  • Postoperative use of opioids
  • Gallbladder disease

Ondansetron (Ondansetron/Zofran®)


Ondansetron: Serotonin antagonist, antiemetic.

Dosage: 4-8 mg IV as prophylaxis (8 mg is the most effective dose), 2 mg/ml solution = 2-4 ml.

Standard dose: 4 mg x 2 IV for PONV.

Warning: Not for children under 2 years old. Previous reactions to selective serotonin antagonists. Should not be used during the first trimester of pregnancy.

Atropine (Atropine®)


Anticholinergic.

Dosage: 0.5 mg IV as prophylaxis = 1 ml. 0.5 mg/ml solution. Counteracts bradycardia and nausea secondary to gastric retention and vomiting. Can be repeated up to a maximum of 1 mg per treatment session.

Standard dose: 0.5 mg x 1 IV for PONV and bradycardia episodes.

Warning: Caution in tachycardia, cardiac ischemia, hyperthermia, urinary retention, accommodation difficulties, confusion.

Betamethasone (Betapred®)


Water-soluble glucocorticoid, antiemetic. Lacks mineralocorticoid effect.

Dosage: 4 mg IV as prophylaxis, 4 mg/ml solution = 1 ml.

Standard dose: 4 mg x 1 IV for PONV.

Warning: Caution in osteoporosis, vertebral compression fractures, newly created intestinal anastomoses, psychosis, mania, gastric ulcers, tuberculosis, diabetes (increases blood sugar), hyperglycemia, hypertension, heart failure.

Dexamethasone (Dexamethasone®)


A synthetic corticosteroid with mainly glucocorticoid effect, antiemetic.

Dosage: 8-16 mg PO as treatment.

Standard dose: 8 mg x 1 PO for PONV.

Warning: Caution in osteoporosis, vertebral compression fractures, newly created intestinal anastomoses, psychosis, mania, gastric ulcers, tuberculosis, diabetes (increases blood sugar), hyperglycemia, hypertension, heart failure.

Droperidol (Dridol®)


Dopamine antagonist, neuroleptic, antiemetic. Vasodilator.

Dosage: 0.5-2.5 mg (most effective dose 1 mg), 0.2-1 ml, 2.5 mg/ml solution.

Standard dose: 0.4 ml, 1 mg. ECG monitoring 2-3 hours after injection.

Side effects: Nightmares, stiffness, rigidity, dystonias.

Warning: QT prolongation, pheochromocytoma.

Granisetron (Kytril®)


Antiemetic, serotonin antagonist.

Dosage: 3 mg IV as prophylaxis, 1 mg/ml solution = 3 ml. An additional dose may be given per day. Max 6 mg per day.

Standard dose: 3 mg (3 ml) given slowly intravenously for PONV.

Warning: Subileus. Severely impaired liver function. Previous reactions to selective serotonin antagonists.

Metoclopramide (Primperan®)


Antiemetic, dopamine receptor blocker. Metoclopramide has a centrally acting antiemetic effect and a prokinetic effect on the gastrointestinal tract.

Dosage: 5-10 mg IV as prophylaxis, 5 mg/ml solution = 1-2 ml. An additional dose may be given per day. Max 10 mg per day. 0.15 mg/kg for children.

Standard dose: 5 mg (1 ml) given slowly intravenously for PONV.

Note: Extrapyramidal side effects may occur, including stiffness and rigidity. Should not be given in known epilepsy as it lowers the seizure threshold.

Female patient checks her surgical wound after undergoing surgery

Oxygen


Oxygen can counteract nausea secondary to hypoxia.

Dosage: Given via nasal cannula 2 l/min or via breathing mask 5 l/min.

Standard dose: 2 l/min in nasal cannula for PONV.

Warning: Caution in respiratory insufficiency (advanced COPD) and hypoventilation.

The time a gas bottle with oxygen ("bomb") is enough at different flows and pressures

Gas cylinder sizePressure (bar)2 l/min3 l/min5 l/min10 l/min
1 liter2001 hour 40 min1 hour 30 min20 min
1501 hour 15 min50 min30 min15 min
10050 min33 min20 min10 min
5025 min17 min10 min5 min
2,5 liter2004 hour 10 min2 tim 45 min1 tim 40 min50 min
1503 hour 2 hour 1 tim 15 min38 min
1002 hour 1 hour 20 min50 min25 min
501 hour 50 min25 min13 min
5 liter2008 hours 20 min5 hours 30 min3 hours 20 min1 hour 40 min
1506 hours 15 min4 hours 10 min2 hours 30 min1 hour 15 min
1004 hours 20 min2 hours 45 min1 hour 40 min38 min
502 hours1 hour 20 min50 min25 min

 




Close Menu